SAM
AURA icon

Smartleaf Asset Management’s Aura Biosciences AURA Stock Holding History

Smartleaf Asset Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1K Buy
1,790
+49
+3% +$281 ﹤0.01% 2276
2025
Q4 		$9.56K Buy
1,741
+478
+38% +$2.84K ﹤0.01% 2416
2025
Q3 		$7.79K Buy
1,263
+429
+51% +$2.81K ﹤0.01% 2210
2025
Q2 		$5.24K Buy
834
+183
+28% +$1.07K ﹤0.01% 2033
2025
Q1 		$4.13K Buy
651
+456
+234% +$3.45K ﹤0.01% 2255
2024
Q4 		$1.58K Buy
195
+86
+79% +$809 ﹤0.01% 2581
2024
Q3 		$984 Buy
+109
New +$935 ﹤0.01% 2661

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Smartleaf Asset Management's AURA Position: Q1 2026 in Review

Smartleaf Asset Management increased its Aura Biosciences (AURA) stake by 2.8% in Q1 2026, buying an estimated $281 and bringing the position to 1,790 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2276.

Smartleaf Asset Management first reported a position in AURA in Q3 2024 and has held it in 7 quarters since. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Smartleaf Asset Management held 1,790 shares of Aura Biosciences worth $11.1K as of Q1 2026.
  • Smartleaf Asset Management bought 49 Aura Biosciences shares in Q1 2026, an estimated $281.
  • Aura Biosciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2276 holding.
  • Smartleaf Asset Management first reported a position in Aura Biosciences in Q3 2024 and has held it in 7 quarters since.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.